NBNRX
Price
$15.20
Change
-$0.03 (-0.20%)
Updated
Oct 6 closing price
Net Assets
251.89M
REREX
Price
$63.86
Change
-$0.08 (-0.13%)
Updated
Oct 6 closing price
Net Assets
138.77B
Interact to see
Advertisement

NBNRX vs REREX

Header iconNBNRX vs REREX Comparison
Open Charts NBNRX vs REREXBanner chart's image
Neuberger Berman International Sel R3
Price$15.20
Change-$0.03 (-0.20%)
VolumeN/A
Net Assets251.89M
American Funds EUPAC R4
Price$63.86
Change-$0.08 (-0.13%)
VolumeN/A
Net Assets138.77B
NBNRX vs REREX Comparison Chart in %
View a ticker or compare two or three
VS
NBNRX vs. REREX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBNRX is a StrongBuy and REREX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REREX has more cash in the bank: 139B vs. NBNRX (252M). REREX (0.68) and NBNRX (0.65) have matching dividends . NBNRX was incepted earlier than REREX: NBNRX (16 years) vs REREX (23 years). NBNRX (1.61) is less costly to investors than REREX (0.82). NBNRX is a more actively managed with annual turnover of: 69.00 vs. REREX (35.00). NBNRX has a lower initial minimum investment than REREX: NBNRX (0) vs REREX (250). REREX annual gain was more profitable for investors over the last year : 10.81 vs. NBNRX (8.73). NBNRX (14.92) and REREX (14.88) have equivalent 5 years return.
NBNRXREREXNBNRX / REREX
Total Expense Ratio1.410.82172%
Annual Report Gross Expense Ratio1.610.82196%
Fund Existence16 years23 years-
Gain YTD19.17122.08087%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets252M139B0%
Annual Yield % from dividends0.650.6896%
Returns for 1 year8.7310.8181%
Returns for 3 years48.5550.2797%
Returns for 5 years14.9214.88100%
Returns for 10 years50.0342.94117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
CRL174.95-2.38
-1.34%
Charles River Laboratories International
THM1.82-0.05
-2.67%
International Tower Hill Mines Ltd
TELA1.51-0.04
-2.88%
TELA Bio
VRDN20.83-0.82
-3.79%
Viridian Therapeutics